DMAC vs IFF · $157.4M cap vs P/E 24, rev $11.48B
DiaMedica Therapeutics Inc (DMAC) versus International Flavors & Fragrances Inc (IFF) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
International Flavors & Fragrances Inc (IFF) is a specialty chemicals company listed on NYSE.
DMAC does not have a complete income-statement cache yet.
Latest reported IFF revenue for 2024-12-31 was $11.48B. Net income was $247.0M. Revenue was up 0.0% from 2023-12-31 to 2024-12-31. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
DMAC currently screens at market cap $157.4M. IFF currently screens at market cap $19.42B and trailing P/E 23.5.
Not investment advice. Open the DMAC and IFF stock pages for the full models.
Not investment advice.